The prevalence of Chlamydia infection in the United Kingdom (Uk): A critical review

Onolunosen Abel Abhadionmhen * and Edobor Peter Kenneth Imarenezor

Department of Microbiology, Federal University Wukari, Taraba State, Nigeria.
 
Review
International Journal of Scientific Research Updates, 2022, 04(01), 329–333.
Article DOI: 10.53430/ijsru.2022.4.1.0145
Publication history: 
Received on 13 August 2022; revised on 26 September 2022; accepted on 28 September 2022
 
Abstract: 
The global overwhelming prevalence of Chlamydia trachomatis may not be unconnected to the asymptomatic nature of the infection. Over 50% of Chlamydia cases can only be detected through diagnosis. Chlamydia is the most diagnosed sexually transmitted infection in the United Kingdom and higher rates of infection are found in women than in men. Over 64% of diagnosed cases of Chlamydia in the UK are among young adults who are between the ages of 16-24 owing to their risky sexual behaviors. Chlamydia is most blame able for urethritis in both men and women. Although there is no currently known vaccine against Chlamydia trachomatis however, Chlamydial infection is preventable using condoms and treatable using antibiotics. Various programs and policies such as the National Chlamydia Screening Program NSCP have been inaugurated in the UK to encourage routine screening of all sexually active individuals and those who are particularly at risk. Although, the need to intensify more efforts towards effecting positive behavioral change among individuals with risky sexual behaviour. Also, more screening centres should be instituted at various locations easily accessible to individuals who are vulnerable to Chlamydial infection.
 
Keywords: 
Chlamydia trachomatis; United Kingdom; Epidemiology; Behavioral Change; Sexually Transmitted Infection
 
Full text article in PDF: